b6 semaglutide Starting Dose: Titration Context Anyone start on this dose

[DOI] [PubMed] [Google Scholar] 25.Griffin WC, III, Lopez MF, Yanke AB, Middaugh LD, Becker HC

M.ElshafeeyA

Liu, C., Kou, Y., Zhang, X., Cheng, H., Chen, X

The US Food and Drug Administration (FDA) has approved Wegovy to: Reduce body weight and support long-term weight loss in people with obesity or with overweight and a weight-related health condition, such as type 2 diabetes or sleep apnea Reduce the risk of experiencing a major cardiovascular event , such as heart attack, stroke, or death, in people with heart disease and obesity or overweight Typically, healthcare providers prescribe a starting dose of 0.25 mg weekly